Podcast: What’s Taurine and Why Do We Care? (Part 2)
Why It Matters
Understanding taurine’s limited proven effects and safety gaps helps consumers and clinicians avoid premature supplementation and informs research priorities for age‑related cardiovascular health.
Key Takeaways
- •Taurine levels decline with age, affecting healthspan in animal models.
- •Human trials show modest blood pressure and triglyceride reductions.
- •No significant impact on blood sugar, LDL, or weight observed.
- •High doses may cause side effects and unknown long‑term safety.
- •Lack of patentability limits funding for large, long‑term human studies.
Summary
The podcast episode examines taurine, a conditionally non‑essential amino acid, its age‑related decline, and whether supplementation can extend human healthspan.
Animal work shows that restoring taurine in mice, worms and monkeys reverses age‑related decline and lengthens lifespan. Human meta‑analyses (2020, 2024) report modest reductions in systolic blood pressure, triglycerides, and a six‑point drop in fasting glucose, but no meaningful changes in LDL cholesterol, body weight, or overall glycemic control.
Specific trials cited include a two‑week, 1.5 g/day study in type‑1 diabetics that improved arterial function, and a 12‑week pre‑hypertension trial (1.6 g/day) that lowered pressure and enhanced arterial compliance. Safety signals such as dizziness, gastrointestinal upset, and potential interactions in kidney disease, bleeding disorders, and psoriasis are also highlighted.
Because taurine cannot be patented, large, long‑term funding is scarce, leaving clinicians without robust evidence. Until well‑designed human trials confirm benefits and safety, routine supplementation remains speculative, especially for older adults seeking longevity benefits.
Comments
Want to join the conversation?
Loading comments...